Adenosine A2a receptor/dopamine D2 receptor hetero-oligomerization: A hypothesis that may explain behavioral sensitization to psychostimulants and schizophrenia

Medical Hypotheses

Volumn 64, Issue 1, 2005, Pages 197-200

  Tsai, Shih Jen ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2A RECEPTOR; AMPHETAMINE; BROMOCRIPTINE; CLOZAPINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; NEUROTRANSMITTER; PSYCHOSTIMULANT AGENT;

BEHAVIOR; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG RESPONSE; DRUG SENSITIZATION; HUMAN; HYPOTHESIS; MOLECULAR INTERACTION; NONHUMAN; OLIGOMERIZATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; REVIEW; SCHIZOPHRENIA;

EID: 7944233161     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.04.018     Document Type: Article

References (29)

1. Lieberman J.A., Sheitman B.B., Kinon B.J. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology. 17:1997;205-229
2. Glenthoj B.Y., Hemmingsen R. Dopaminergic sensitization: implications for the pathogenesis of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry. 21:1997;23-46
3. Guieu R., Dussol B., Halimi G., Bechis G., Sampieri F., Berland Y., et al. Adenosine and the nervous system: pharmacological data and therapeutic perspectives. Gen. Pharmacol. 31:1998;553-561
4. Sebastiao A.M., Ribeiro J.A. Fine-tuning neuromodulation by adenosine. Trends Pharmacol. Sci. 21:2000;341-346
5. Schiffmann S.N., Jacobs O., Vanderhaeghen J.J. Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J. Neurochem. 57:1991;1062-1067
6. Fink J.S., Weaver D.R., Rivkees S.A., Peterfreund R.A., Pollack A.E., Adler E.M., et al. Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. Brain. Res. Mol. Brain. Res. 14:1992;186-195
7. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain. Res. Brain. Res. Rev. 25:1997;192-216
8. Csernansky J.G., Bardgett M.E. Limbic-cortical neuronal damage and the pathophysiology of schizophrenia. Schizophr. Bull. 24:1998;231-248
9. Popoli P., Pezzola A., de Carolis A.S. Modulation of striatal adenosine A1 and A2 receptors induces rotational behaviour in response to dopaminergic stimulation in intact rats. Eur. J. Pharmacol. 257:1994;21-25
10. Ferre S., von Euler G., Johansson B., Fredholm B.B., Fuxe K. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc. Natl. Acad. Sci. USA. 88:1991;7238-7241
11. Hillion J., Canals M., Torvinen M., Casado V., Scott R., Terasmaa A., et al. Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J. Biol. Chem. 277:2002;18091-18097
12. Kamiya T., Saitoh O., Yoshioka K., Nakata H. Oligomerization of adenosine A2A and dopamine D2 receptors in living cells. Biochem. Biophys. Res. Commun. 306:2003;544-549
13. Tsai S.J., Hong C.J. Dopamine receptor hetero-oligomerization: a hypothesis for behavioral sensitization to psychostimulants. Med. Hypotheses. 61:2003;18-20
14. Tsai S.J., Hong C.J. Dopamine receptor hetero-oligomerization in the pathogenesis of schizophrenia: qualitative as opposed to quantitative notions of dopaminergic receptors. Schizophr. Res. 63:2003;197-198
15. Chen J.F., Moratalla R., Yu L., Martin A.B., Xu K., Bastia E., et al. Inactivation of adenosine A2A receptors selectively attenuates amphetamine-induced behavioral sensitization. Neuropsychopharmacology. 28:2003;1086-1095
16. Shimazoe T., Yoshimatsu A., Kawashimo A., Watanabe S. Roles of adenosine A(1) and A(2A) receptors in the expression and development of methamphetamine-induced sensitization. Eur. J. Pharmacol. 388:2000;249-254
17. Fenu S., Cauli O., Morelli M. Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A(2A) receptors. Behav. Brain. Res. 114:2000;97-105
18. Rocheville M., Lange D.C., Kumar U., Patel S.C., Patel R.C., Patel Y.C. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science. 288:2000;154-157
19. Cavalli V., Corti M., Gruenberg J. Endocytosis and signaling cascades: a close encounter. FEBS Lett. 498:2001;190-196
20. Jordan B.A., Trapaidze N., Gomes I., Nivarthi R., Devi L.A. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc. Natl. Acad. Sci. USA. 98:2001;343-348
21. Liu F., Wan Q., Pristupa Z.B., Yu X.M., Wang Y.T., Niznik H.B. Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors. Nature. 403:2000;274-280
22. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse. 1:1987;133-152
23. Lucas P.B., Pickar D., Kelsoe J., Rapaport M., Pato C., Hommer D. Effects of the acute administration of caffeine in patients with schizophrenia. Biol. Psychiatry. 28:1990;35-40
24. Bassett A.S., Chow E.W., Weksberg R. Chromosomal abnormalities and schizophrenia. Am. J. Med. Genet. 97:2000;45-51
25. Ferre S., Schwarcz R., Li X.M., Snaprud P., Ogren S.O., Fuxe K. Chronic haloperidol treatment leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum. Psychopharmacology. 116:1994;279-284
26. Parsons B., Togasaki D.M., Kassir S., Przedborski S. Neuroleptics up-regulate adenosine A2a receptors in rat striatum: implications for the mechanism and the treatment of tardive dyskinesia. J. Neurochem. 65:1995;2057-2064
27. Pinna A., Wardas J., Cozzolino A., Morelli M. Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol. Neuropsychopharmacology. 20:1999;44-51
28. Akhondzadeh S., Shasavand E., Jamilian H., Shabestari O., Kamalipour A. Dipyridamole in the treatment of schizophrenia: adenosine-dopamine receptor interactions. J. Clin. Pharm. Ther. 25:2000;131-137
29. Andersen M.B., Fuxe K., Werge T., Gerlach J. The adenosine A2A receptor agonist CGS 21680 exhibits antipsychotic-like activity in Cebus apella monkeys. Behav. Pharmacol. 13:2002;639-644